Compare the 11 manufacturers holding an active US Drug Master File for Cetrorelix API, with DMF numbers and filing years from the FDA's quarterly DMF list.
Directory listing last reviewed October 2026.
11 manufacturers hold an active Type II Drug Master File for CetrorelixAPI, taken from the FDA's quarterly DMF list; 10 of them are listed in this directory. A DMF lets a drug applicant reference the maker's manufacturing data. It is not an FDA approval. Check each manufacturer against the FDA import alert lists before ordering.
| Manufacturer | Location | US DMF | Filed |
|---|---|---|---|
| ALP Pharm Beijing | China (Beijing) | 33914 | 2019 |
| Piramal Pharma Solutions | India (Mumbai) | 34552 | 2020 |
| Sun Pharmaceutical IndustriesFDA import alert | India (Mumbai) | 34704 | 2020 |
| Biophore India Pharmaceuticals | India (Hyderabad) | 34752 | 2020 |
| Chinese Peptide Company (Medtide) | China (Hangzhou) | 34884 | 2020 |
| Sinopep Biopharma | China | 35171 | 2020 |
| Hybio Pharmaceutical | China | 37082 | 2022 |
| BCN Peptides | Spain (Barcelona) | 38264 | 2023 |
| Harbin Jixianglong BiotechFDA import alert | China (Harbin) | 39986 | 2024 |
| Apicore (RK Pharma) | USA (East Windsor, NJ) | 41854 | 2025 |
Not yet listed in this directory, so we have not reviewed them. Names as printed in the FDA DMF list.
| DMF holder | US DMF | Filed |
|---|---|---|
| Merck Healthcare KGaA | 18077 | 2005 |
Request API quotes from several manufacturers at once. Hold a Cetrorelix DMF and not listed? Add your company.